GlassScriptPhysician profile
Jennifer Cho
NPI 1033265491
$2,089.31
in general payments reported to CMS, 2019-2025
22 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $129 · 2021: $416 · 2022: $380 · 2023: $465 · 2024: $260 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675 · Education: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.43 |
| Education | $304.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $378.03 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $366.14 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $139.86 | 2023-2025 | |
| Agile Therapeutics, INC. | $134.28 | 2021-2023 | Twirla |
| Avion Pharmaceuticals | $129.87 | 2019-2022 | |
| Daiichi Sankyo INC. | $127.00 | 2021-2022 | |
| Myovant Sciences INC. | $123.54 | 2021-2022 | |
| Hologic Sales and Service, LLC | $123.30 | 2021-2025 | Myosure Tissue Removal Device |
| Amgen INC. | $106.08 | 2024-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $92.13 | 2023-2024 | |
| Exeltis, USA INC. | $75.39 | 2023-2024 | Slynd |
| Lupin INC. | $65.26 | 2019-2021 | |
| Dysis Medical, INC. | $52.50 | 2020-2022 | |
| Coopersurgical, INC. | $26.68 | 2021-2022 | |
| Scynexis, INC. | $25.68 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25.17 | 2019-2025 | Gardasil 9 |
| Becton, Dickinson and Company | $19.95 | 2021 | |
| Meditrina | $19.47 | 2021 | |
| Ge Healthcare | $18.30 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $14.92 | 2023 | Vivjoa |
| Assertio Therapeutics, INC. | $12.95 | 2019 | |
| Minerva Surgical, INC | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.